Recruiting

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.

ClinicalTrials.gov IDNCT06478589

PhasePHASE2

Enrollment120

SponsorThe University of Texas Health Science Center, Houston

Age65 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Cancer Survivorship

About this study

Interventions

Behavioral: Adapted Patient Priorities Care (PPC) approach — Step 1 is a PPC facilitation encounter, at which the facilitator will help the participant identify patient priorities, such as clarifying values (what matters most); setting meaningful, specific, and realistic outcome goals; describing healthcare preferences (care that is helpful and/or burdensome) and tradeoffs; and discussing priorities with clinicians. The participant's healthcare priorities are then documented and transmitted to clinicians, in order to facilitate changes in the patient's care plan to align it with his/her priorities. In step 2, the clinician considers patient's priorities and potential healthcare options (options might include starting or stopping treatments; adding or removing medications; ordering more or fewer tests; recommending or removing self-management tasks). In step 3, the clinician discusses care options with the participant, using strategies for aligning care with patient priorities.
Other: Usual Care — Usual care for breast cancer survivorship includes regular visits with the oncology provider and yearly mammograms for surveillance.

Primary outcomes

Treatment burden as assessed by the treatment burden questionnaire (TBQ) (baseline)
Treatment burden as assessed by the treatment burden questionnaire (TBQ) (3 months)
Treatment burden as assessed by the treatment burden questionnaire (TBQ) (6 months)
Health status as assessed by the Functional Assessment of Cancer Therapy - Breast (FACT-B) (baseline)
Health status as assessed by the Functional Assessment of Cancer Therapy - Breast (FACT-B) (3 months)
Health status as assessed by the Functional Assessment of Cancer Therapy - Breast (FACT-B) (6 months)

Eligibility information

Inclusion Criteria: * able to write and speak English * Stage DCIS/I/II/III breast cancer diagnosis * 3 months from active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment) up to 10 years since completing treatment * ≥3 documented comorbidities by chart review, or taking ≥10 medications, have ≥ 1 hospitalization over the past year, ≥ 2 emergency department visits over the past year, seen by \> 2 specialists over the past year * able to provide consent Exclusion Criteria: * currently on active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment)

Study locations

UT Physicians Center for Healthy Aging Bellaire, Bellaire, Texas 77401 United States
UT Physicians Family Medicine Bayshore, Houston, Texas 77006 United States
Memorial Hermann Cancer Center, Houston, Texas 77030 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.